Medical Device News Magazine

SleepOvation Baby’s Crib Mattress Receives FDA Listing

Breakthrough Multi-Patented Crib Mattress Features Advanced Technology that Creates the Most Breathable Mattress While Alleviating Harmful Pressure to the Head

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

SleepOvation Baby, an FDA registered manufacturer of medical devices, today announced that its crib mattress has been listed by the FDA for sale. With this listing, parents can shop with confidence knowing that SleepOvation Baby’s crib mattress is safe and effective for babies.

“SleepOvation Baby is thrilled to obtain this FDA listing and give parents peace of mind when choosing a crib mattress, which is one of the most important purchases they make for their babies,” said Marty Lacoff, Chief Strategy Officer and Co-Founder of SleepOvation Baby. “We believe in the power of better and safer sleep, and we are proud to bring the safest and most advanced crib mattress solution to families everywhere.”

Trusted by parents and backed by science, SleepOvation’s baby mattress is the most breathable on the market today. It is the first and only crib mattress engineered with individual coil springs married to individual cushion elements to create air channels designed for optimal breathability, as part of its 8-patent design to increase airflow, help prevent babies from overheating, and support a longer and more restful sleep.

This patented mattress is also designed to alleviate harmful pressure on the head that can cause bruises, sores, and physical deformities in infants. There is a known correlation between high pressure and the development of positional plagiocephaly (flat head syndrome) in infants. Studies have shown that babies with flat head syndrome may be at heightened risk of developmental delays, including motor, language, and cognitive delaysi. SleepOvation’s patented technology distributes the high spot forces over a larger portion of the baby’s head, thereby eliminating the harmful pressures exerted on babies’ heads during sleep.

Other features include a water-resistant infant side and waterproof toddler side, and a removable, washable, and breathable organic blend cover, making it the cleanest infant mattress available. To support healthy development, both sides of the crib mattress also help ensure proper spine alignment.

SleepOvation Baby’s commitment to providing the safest, healthiest crib mattress is built upon using the highest quality, non-toxic materials for every component. Materials include CertiPUR-US® Certified foam, OEKO-TEX® STANDARD 100 fabrics, and UL GREENGUARD Gold Certified adhesives, and its construction meets all ASTM F2933-19 Standard Consumer Safety Specifications for Crib Mattresses. The mattress is also fiberglass-free. 100% U.S.A. made and manufactured, all materials are sourced in the U.S. and the mattress is produced in New Jersey at a state-of-the-art facility with stringent safety standards.

SleepOvation Baby’s crib mattress has received numerous positive reviews from parents across the U.S. and Canada, and has appeared in media such as The Bump, Spy, and Sleep Foundation, among others. It also earned recognition in the 2022 National Parenting Product Awards (NAPPA).

The SleepOvation Baby crib mattress is available in two sizes: standard and mini. The standard size retails for $499. For more information, visit www.sleepovationbaby.com.

________________________
i
https://www.sciencedaily.com/releases/2017/01/170124111344.htm

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”